Filter announcements
Loading...
Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals
Aarti Pharmalabs received an order for a Rs. 59.50 Cr stamp duty and penalty related to its demerger scheme. The company will challenge this, believing it has a strong legal case.
Aarti Pharmalabs Limited has informed the Exchange about change in Management
Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication
Aarti Pharmalabs published its FY26 Sustainability Report, highlighting strong ESG initiatives including 100% human rights training & Zero Liquid Discharge. The company is actively investing in renewable energy and sustainable sourcing. A penalty of `0.026 Cr was paid for alleged GST discrepancies.
Aarti Pharmalabs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 22, 2026